( NASDAQ-SMALL:CTSO )

News from CytoSorbents Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

24 May, 2017, 08:05 ET CytoSorbents Selected to Present at Special Operations SOMSA 2017 Conference and 18th Annual B. Riley & Co. Investor Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...


22 May, 2017, 09:00 ET Aferetica and CytoSorbents Extend Exclusive "Life-saving" Partnership through 2021

Aferetica srl, an innovative start-up specializing in blood purification, and CytoSorbents Corporation (NASDAQ: CTSO), a critical care...


08 May, 2017, 16:30 ET CytoSorbents Reports First Quarter 2017 Financial Results

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to prevent or...


05 May, 2017, 09:00 ET CytoSorbents Announces Positive REFRESH I Trial Results

Positive results from the REFRESH (REduction in FREe Hemoglobin) I trial were presented on Monday, May 1, 2017 at the American Association for...


02 May, 2017, 07:00 ET CytoSorbents to Report Q1 2017 Operating and Financial Results

CytoSorbents Corporation (CTSO), CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood...


19 Apr, 2017, 08:30 ET CytoSorbents 2017 - Propelling the Company to the "Next Level"

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


31 Mar, 2017, 08:00 ET CytoSorbents Announces Pricing of Follow-On Offering

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


30 Mar, 2017, 16:01 ET CytoSorbents Announces Proposed Offering of Common Stock

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


28 Mar, 2017, 07:15 ET CytoSorbents Strengthens Intellectual Property Portfolio with New Patents Issued in the U.S., China, Japan, Russia, and Australia

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


27 Mar, 2017, 07:08 ET CytoSorbents REFRESH I Trial Abstract Selected for Podium Presentation at the American Association for Thoracic Surgery Centennial Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


22 Mar, 2017, 07:15 ET Dr. Carl H. June, Cancer Immunotherapy Pioneer, Joins CytoSorbents Scientific Advisory Board

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


20 Mar, 2017, 07:30 ET CytoSorb® Treatment of HLH - The Parallel to Cytokine Release Syndrome in Cancer Immunotherapy

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


16 Mar, 2017, 07:00 ET CytoSorbents Announces CytoSorb® Partnership with Dr. Reddy's Laboratories

CytoSorbents Corporation (NASDAQ: CTSO), manufacturer of the CytoSorb® extracorporeal blood purification therapy that reduces excessive levels of...


07 Mar, 2017, 08:00 ET CytoSorbents Highlights Activities at the 22nd International Conference on Advances in Critical Care Nephrology

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


06 Mar, 2017, 07:00 ET CytoSorbents to Present at the Maxim Group - Haitong Securities Inaugural Healthcare Investor and Partnering Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


03 Mar, 2017, 07:00 ET CytoSorbents Reports Record Quarterly and Full-Year 2016 Revenue

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to prevent or...


02 Mar, 2017, 07:00 ET CytoSorbents to Present at 37th Annual Cowen and Company Healthcare Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in...


24 Feb, 2017, 07:00 ET CytoSorbents to Report Fiscal 2016 Operating and Financial Results

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in...


07 Feb, 2017, 08:00 ET CytoSorbents to Present at the 19th Annual BIO CEO & Investor Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in...


20 Jan, 2017, 09:00 ET CytoSorbents Launches VetResQ™ for U.S. Veterinary Market

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in...


11 Jan, 2017, 02:00 ET Fresenius Medical Care y CytoSorbents firman un nuevo acuerdo de marketing para CytoSorb®

- Fresenius Medical Care y CytoSorbents expanden su asociación original y firman un nuevo acuerdo de marketing conjunto para los mercados...


11 Jan, 2017, 02:00 ET Fresenius Medical Care und CytoSorbents erweitern ursprüngliche Partnerschaft und fügen neue Co-Marketing-Vereinbarung für CytoSorb®-Märkte weltweit hinzu

Vereinbarung verstärkt Engagement mit 3-jähriger Verlängerung und garantierten CytoSorb-Mindestbestellmengen, und schafft gemeinsame...


11 Jan, 2017, 02:00 ET Fresenius Medical Care et CytoSorbents élargissent leur partenariat initial et ajoutent un nouvel accord de co-marketing pour les marchés CytoSorb® à l'échelle mondiale

L'accord renforce leur engagement avec un renouvellement de 3 ans, des commandes minimum garanties de CytoSorb, et établit des initiatives de...


10 Jan, 2017, 09:00 ET CytoSorbents Pre-announces Q4 2016 and Full-Year 2016 Results

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


09 Jan, 2017, 08:00 ET Fresenius Medical Care and CytoSorbents Expand Original Partnership and Add New Co-Marketing Agreement for Worldwide CytoSorb® Markets

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood adsorber to treat deadly...